These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 27016602)
1. Defining Viral Defective Ribosomal Products: Standard and Alternative Translation Initiation Events Generate a Common Peptide from Influenza A Virus M2 and M1 mRNAs. Yang N; Gibbs JS; Hickman HD; Reynoso GV; Ghosh AK; Bennink JR; Yewdell JW J Immunol; 2016 May; 196(9):3608-17. PubMed ID: 27016602 [TBL] [Abstract][Full Text] [Related]
2. RNA polymerase II inhibitors dissociate antigenic peptide generation from normal viral protein synthesis: a role for nuclear translation in defective ribosomal product synthesis? Dolan BP; Knowlton JJ; David A; Bennink JR; Yewdell JW J Immunol; 2010 Dec; 185(11):6728-33. PubMed ID: 21048111 [TBL] [Abstract][Full Text] [Related]
3. The accumulation of influenza A virus segment 7 spliced mRNAs is regulated by the NS1 protein. Robb NC; Fodor E J Gen Virol; 2012 Jan; 93(Pt 1):113-118. PubMed ID: 21918006 [TBL] [Abstract][Full Text] [Related]
5. Defective ribosomal products are the major source of antigenic peptides endogenously generated from influenza A virus neuraminidase. Dolan BP; Li L; Takeda K; Bennink JR; Yewdell JW J Immunol; 2010 Feb; 184(3):1419-24. PubMed ID: 20038640 [TBL] [Abstract][Full Text] [Related]
6. Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines. Nogales A; DeDiego ML; Topham DJ; Martínez-Sobrido L J Virol; 2016 Jul; 90(14):6291-6302. PubMed ID: 27122587 [TBL] [Abstract][Full Text] [Related]
7. Influenza virus mRNA trafficking through host nuclear speckles. Mor A; White A; Zhang K; Thompson M; Esparza M; Muñoz-Moreno R; Koide K; Lynch KW; García-Sastre A; Fontoura BM Nat Microbiol; 2016 May; 1(7):16069. PubMed ID: 27572970 [TBL] [Abstract][Full Text] [Related]
8. Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. Bullock TN; Eisenlohr LC J Exp Med; 1996 Oct; 184(4):1319-29. PubMed ID: 8879204 [TBL] [Abstract][Full Text] [Related]
9. Influenza A Virus NS1 Protein Promotes Efficient Nuclear Export of Unspliced Viral M1 mRNA. Pereira CF; Read EKC; Wise HM; Amorim MJ; Digard P J Virol; 2017 Aug; 91(15):. PubMed ID: 28515301 [TBL] [Abstract][Full Text] [Related]
10. The choice of alternative 5' splice sites in influenza virus M1 mRNA is regulated by the viral polymerase complex. Shih SR; Nemeroff ME; Krug RM Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6324-8. PubMed ID: 7541537 [TBL] [Abstract][Full Text] [Related]
11. Leucine-tRNA initiates at CUG start codons for protein synthesis and presentation by MHC class I. Starck SR; Jiang V; Pavon-Eternod M; Prasad S; McCarthy B; Pan T; Shastri N Science; 2012 Jun; 336(6089):1719-23. PubMed ID: 22745432 [TBL] [Abstract][Full Text] [Related]
12. Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein. Zebedee SL; Lamb RA Proc Natl Acad Sci U S A; 1989 Feb; 86(3):1061-5. PubMed ID: 2915973 [TBL] [Abstract][Full Text] [Related]
13. An A14U Substitution in the 3' Noncoding Region of the M Segment of Viral RNA Supports Replication of Influenza Virus with an NS1 Deletion by Modulating Alternative Splicing of M Segment mRNAs. Zheng M; Wang P; Song W; Lau SY; Liu S; Huang X; Mok BW; Liu YC; Chen Y; Yuen KY; Chen H J Virol; 2015 Oct; 89(20):10273-85. PubMed ID: 26223635 [TBL] [Abstract][Full Text] [Related]
14. Targeting HIV-1 Gag into the defective ribosomal product pathway enhances MHC class I antigen presentation and CD8+ T cell activation. Goldwich A; Hahn SS; Schreiber S; Meier S; Kämpgen E; Wagner R; Lutz MB; Schubert U J Immunol; 2008 Jan; 180(1):372-82. PubMed ID: 18097038 [TBL] [Abstract][Full Text] [Related]
15. Mutations at alternative 5' splice sites of M1 mRNA negatively affect influenza A virus viability and growth rate. Chiang C; Chen GW; Shih SR J Virol; 2008 Nov; 82(21):10873-86. PubMed ID: 18768984 [TBL] [Abstract][Full Text] [Related]
16. Mutations in the Influenza A Virus M1 Protein Enhance Virus Budding To Complement Lethal Mutations in the M2 Cytoplasmic Tail. Liu H; Grantham ML; Pekosz A J Virol; 2018 Jan; 92(1):. PubMed ID: 29046451 [TBL] [Abstract][Full Text] [Related]
17. Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Lamb RA; Lai CJ; Choppin PW Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4170-4. PubMed ID: 6945577 [TBL] [Abstract][Full Text] [Related]
18. Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. Malarkannan S; Horng T; Shih PP; Schwab S; Shastri N Immunity; 1999 Jun; 10(6):681-90. PubMed ID: 10403643 [TBL] [Abstract][Full Text] [Related]
19. The influenza A virus spliced messenger RNA M mRNA3 is not required for viral replication in tissue culture. Jackson D; Lamb RA J Gen Virol; 2008 Dec; 89(Pt 12):3097-3101. PubMed ID: 19008398 [TBL] [Abstract][Full Text] [Related]
20. Replication of H1N1 influenza viruses in cultured mouse embryo brain cells: virus strain and cell differentiation affect synthesis of proteins encoded in RNA segments 7 and 8 and efficiency of mRNA splicing. Bradshaw GL; Schwartz CD; Schlesinger RW Virology; 1990 Jun; 176(2):390-402. PubMed ID: 2140629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]